Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - China Botanic Pharmaceutical | chinabotanic_ex31-1.htm |
| 10-Q - 10-Q - China Botanic Pharmaceutical | chinabotanic_10q.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of China Botanic Pharmaceutical Inc (the “Company”) on Form 10-Q for the year ended July 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, / Issamar Ginzberg , Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| Dated: September 20, 2021 | By: | /s/ Issamar Ginzberg |
Issamar Ginzberg Chief Executive Officer (Principal
Executive Officer and |